Literature DB >> 28381637

Aminoacyl tRNA Synthetase--Interacting Multifunctional Protein 1 Activates NK Cells via Macrophages In Vitro and In Vivo.

Myun Soo Kim1,2, Ju Han Song1, Edward P Cohen3, Daeho Cho2, Tae Sung Kim4.   

Abstract

Aminoacyl tRNA synthetase-interacting multifunctional protein 1 (AIMP1) has been reported to have antitumor effects in various tumor models. However, mechanisms by which AIMP1 ameliorates tumorigenesis are not well understood. As NK cells are a major cell type involved in antitumor activities and AIMP1 is known to activate professional APCs, we determined whether AIMP1 induced NK cell activation directly or via these APCs. AIMP1 induced the expression of surface activation markers on murine NK cells in total splenocytes, although AIMP1 did not directly induce these activation markers of NK cells. The inductive effect of AIMP1 on NK cell activation disappeared in macrophage-depleted splenocytes, indicating that macrophages were required for the AIMP1-induced activation of NK cells. Furthermore, coculture experiments showed that AIMP1 activated NK cells in the presence of isolated macrophages, but failed to activate NK cells when cultured alone or with dendritic cells or B cells. Although AIMP1 significantly promoted TNF-α production by macrophages, the secreted TNF-α partially affected the NK cell activation. Transwell cocultivation analysis revealed that direct contact between macrophages and NK cells was required for the AIMP1-induced NK cell activation. In addition, AIMP1 significantly enhanced cytotoxicity of NK cells against Yac-1 cells. Furthermore, the in vivo administration of AIMP1 also induced NK cell activation systemically with a macrophage-dependent manner. Importantly, AIMP1 dramatically reduced the lung metastasis of melanoma cells, which was mediated by NK cells. Taken together, our results show that AIMP1 induces antitumor responses by NK cell activation mainly via macrophages.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28381637     DOI: 10.4049/jimmunol.1601558

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  5 in total

Review 1.  Roles of Aminoacyl-tRNA Synthetases in Cancer.

Authors:  Zheng Zhou; Bao Sun; Anzheng Nie; Dongsheng Yu; Meng Bian
Journal:  Front Cell Dev Biol       Date:  2020-11-27

2.  AIMp1 Potentiates TH1 Polarization and Is Critical for Effective Antitumor and Antiviral Immunity.

Authors:  Dan Liang; Lin Tian; Ran You; Matthew M Halpert; Vanaja Konduri; Yunyu C Baig; Silke Paust; Doyeun Kim; Sunghoon Kim; Fuli Jia; Shixia Huang; Xiang Zhang; Farrah Kheradmand; David B Corry; Brian E Gilbert; Jonathan M Levitt; William K Decker
Journal:  Front Immunol       Date:  2018-01-15       Impact factor: 7.561

Review 3.  Aminoacyl-tRNA synthetases, therapeutic targets for infectious diseases.

Authors:  Eun-Young Lee; Sunghoon Kim; Myung Hee Kim
Journal:  Biochem Pharmacol       Date:  2018-06-08       Impact factor: 5.858

4.  Threonyl-tRNA Synthetase Promotes T Helper Type 1 Cell Responses by Inducing Dendritic Cell Maturation and IL-12 Production via an NF-κB Pathway.

Authors:  Hak-Jun Jung; Su-Ho Park; Kyung-Min Cho; Kwang Il Jung; Daeho Cho; Tae Sung Kim
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

Review 5.  Aminoacyl-tRNA Synthetase: A Non-Negligible Molecule in RNA Viral Infection.

Authors:  Min Feng; Han Zhang
Journal:  Viruses       Date:  2022-03-15       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.